ePharmacy Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on EPharmacy Market 

5.1. COVID-19 Landscape: EPharmacy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global EPharmacy Market, By Drug Type

8.1. EPharmacy Market, by Drug Type, 2024-2034

8.1.1. Over-the-counter Drugs

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Prescription Drugs

8.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global EPharmacy Market, By Product Type

9.1. EPharmacy Market, by Product Type, 2024-2034

9.1.1. Skin Care

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Dental

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Cold & Flu

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Vitamins

9.1.4.1. Market Revenue and Forecast (2021-2034)

9.1.5. Weight Loss

9.1.5.1. Market Revenue and Forecast (2021-2034)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global EPharmacy Market, By End-user 

10.1. EPharmacy Market, by End-user, 2024-2034

10.1.1. Hospitals & Clinics

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Primary Care Centers

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Nursing Homes

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Home Care Settings

10.1.4.1. Market Revenue and Forecast (2021-2034)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global EPharmacy Market, By Platform

11.1. EPharmacy Market, by Platform, 2024-2034

11.1.1. App-based

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Web-based

11.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global EPharmacy Market, By Payment Method

12.1. EPharmacy Market, by Payment Method, 2024-2034

12.1.1. Online Payment

12.1.1.1. Market Revenue and Forecast (2021-2034)

12.1.2. Cash On Delivery

12.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 13. Global EPharmacy Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.1.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.1.3. Market Revenue and Forecast, by End-user (2021-2034)

13.1.4. Market Revenue and Forecast, by Platform (2021-2034)

13.1.5. Market Revenue and Forecast, by Payment Method (2021-2034)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.1.6.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.1.6.3. Market Revenue and Forecast, by End-user (2021-2034)

13.1.6.4. Market Revenue and Forecast, by Platform (2021-2034)

13.1.6.5. Market Revenue and Forecast, by Payment Method (2021-2034) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.1.7.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.1.7.3. Market Revenue and Forecast, by End-user (2021-2034)

13.1.7.4. Market Revenue and Forecast, by Platform (2021-2034)

13.1.7.5. Market Revenue and Forecast, by Payment Method (2021-2034)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.2.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.2.3. Market Revenue and Forecast, by End-user (2021-2034)

13.2.4. Market Revenue and Forecast, by Platform (2021-2034) 

13.2.5. Market Revenue and Forecast, by Payment Method (2021-2034) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.2.6.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.2.6.3. Market Revenue and Forecast, by End-user (2021-2034)

13.2.7. Market Revenue and Forecast, by Platform (2021-2034) 

13.2.8. Market Revenue and Forecast, by Payment Method (2021-2034) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.2.9.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.2.9.3. Market Revenue and Forecast, by End-user (2021-2034)

13.2.10. Market Revenue and Forecast, by Platform (2021-2034)

13.2.11. Market Revenue and Forecast, by Payment Method (2021-2034)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.2.12.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.2.12.3. Market Revenue and Forecast, by End-user (2021-2034)

13.2.12.4. Market Revenue and Forecast, by Platform (2021-2034)

13.2.13. Market Revenue and Forecast, by Payment Method (2021-2034)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.2.14.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.2.14.3. Market Revenue and Forecast, by End-user (2021-2034)

13.2.14.4. Market Revenue and Forecast, by Platform (2021-2034)

13.2.15. Market Revenue and Forecast, by Payment Method (2021-2034)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.3.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.3.3. Market Revenue and Forecast, by End-user (2021-2034)

13.3.4. Market Revenue and Forecast, by Platform (2021-2034)

13.3.5. Market Revenue and Forecast, by Payment Method (2021-2034)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.3.6.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.3.6.3. Market Revenue and Forecast, by End-user (2021-2034)

13.3.6.4. Market Revenue and Forecast, by Platform (2021-2034)

13.3.7. Market Revenue and Forecast, by Payment Method (2021-2034)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.3.8.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.3.8.3. Market Revenue and Forecast, by End-user (2021-2034)

13.3.8.4. Market Revenue and Forecast, by Platform (2021-2034)

13.3.9. Market Revenue and Forecast, by Payment Method (2021-2034)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.3.10.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.3.10.3. Market Revenue and Forecast, by End-user (2021-2034)

13.3.10.4. Market Revenue and Forecast, by Platform (2021-2034)

13.3.10.5. Market Revenue and Forecast, by Payment Method (2021-2034)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.3.11.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.3.11.3. Market Revenue and Forecast, by End-user (2021-2034)

13.3.11.4. Market Revenue and Forecast, by Platform (2021-2034)

13.3.11.5. Market Revenue and Forecast, by Payment Method (2021-2034)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.4.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.4.3. Market Revenue and Forecast, by End-user (2021-2034)

13.4.4. Market Revenue and Forecast, by Platform (2021-2034)

13.4.5. Market Revenue and Forecast, by Payment Method (2021-2034)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.4.6.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.4.6.3. Market Revenue and Forecast, by End-user (2021-2034)

13.4.6.4. Market Revenue and Forecast, by Platform (2021-2034)

13.4.7. Market Revenue and Forecast, by Payment Method (2021-2034)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.4.8.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.4.8.3. Market Revenue and Forecast, by End-user (2021-2034)

13.4.8.4. Market Revenue and Forecast, by Platform (2021-2034)

13.4.9. Market Revenue and Forecast, by Payment Method (2021-2034)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.4.10.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.4.10.3. Market Revenue and Forecast, by End-user (2021-2034)

13.4.10.4. Market Revenue and Forecast, by Platform (2021-2034)

13.4.10.5. Market Revenue and Forecast, by Payment Method (2021-2034)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.4.11.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.4.11.3. Market Revenue and Forecast, by End-user (2021-2034)

13.4.11.4. Market Revenue and Forecast, by Platform (2021-2034)

13.4.11.5. Market Revenue and Forecast, by Payment Method (2021-2034)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.5.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.5.3. Market Revenue and Forecast, by End-user (2021-2034)

13.5.4. Market Revenue and Forecast, by Platform (2021-2034)

13.5.5. Market Revenue and Forecast, by Payment Method (2021-2034)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.5.6.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.5.6.3. Market Revenue and Forecast, by End-user (2021-2034)

13.5.6.4. Market Revenue and Forecast, by Platform (2021-2034)

13.5.7. Market Revenue and Forecast, by Payment Method (2021-2034)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Drug Type (2021-2034)

13.5.8.2. Market Revenue and Forecast, by Product Type (2021-2034)

13.5.8.3. Market Revenue and Forecast, by End-user (2021-2034)

13.5.8.4. Market Revenue and Forecast, by Platform (2021-2034)

13.5.8.5. Market Revenue and Forecast, by Payment Method (2021-2034)

Chapter 14. Company Profiles

14.1. The Kroger Co.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Apollo Pharmacy

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. DocMorris

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Walgreen Co.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Rowlands Pharmacy

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Giant Eagle, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Optum Rx, Inc.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Walmart, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. CVS Health

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Express Scripts Holding Company

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms